Does Dr. MARY ANN HUANG have financial conflicts of interest?

Dr. MARY ANN HUANG (M.D.) has received a total of $239,818 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $239,818 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MARY ANN HUANG?

According to CMS Open Payments data, Dr. MARY ANN HUANG received funding from GILEAD SCIENCES ($68,550), MADRIGAL PHARMACEUTICALS ($58,919), and ABBVIE ($55,620).

Does Dr. MARY ANN HUANG receive research grants or speaking fees?

Dr. MARY ANN HUANG has received $239,818 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MARY ANN HUANG

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Gastroenterology

Practice Location: DENVER, CO 80218

NPI Number: 1477621902

LIFETIME INDUSTRY VALUE

$239,818

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. HUANG is a verified Internal Medicine, Gastroenterology practitioner based in DENVER, CO.

Between 2021 and 2025, Dr. HUANG had an overall industry promotional and research financial footprint of $239,818 as recorded in the federal CMS Open Payments database.

$239,818 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. HUANG's primary funding source is GILEAD SCIENCES, which accounts for $68,550 (representing 28.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GILEAD SCIENCES

Rank 1

$68,550

28.6%

MADRIGAL PHARMACEUTICALS

Rank 2

$58,919

24.6%

ABBVIE

Rank 3

$55,620

23.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.